Duet BioTherapeutics is an immunotherapy company creating a new category of bispecific oligonucleotide treatments designed to target dormant immune cells within the tumor microenvironment. Activation of these antigen-presenting cells removes the immunosuppressive shield around the tumor and jump-starts T cell-mediated immune responses to kill cancer cells.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Los Angeles, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.duettx.com/
- HQ
- Los Angeles, CA
Duet Biotherapeutics Questions
Duet Biotherapeutics's website is https://www.duettx.com/
Duet Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/duettx
Duet Biotherapeutics has
1 employees.
View email and phone details for 1
employees at Duet Biotherapeutics.
Duet Biotherapeutics's industry is
Biotechnology Research
Duet Biotherapeutics's top competitors are
Remd Biotherapeutics Inc.,
Fuse Biotherapeutics,
Gemma Biotherapeutics,
Rayzebio,
Carnaby,
Kairos Pharma Ltd. (Nyse: Kapa),
Pepromene Bio,
Aptadir Therapeutics,
Gt Biopharma, Inc.,
Concept Bio | A Biotech Venture Studio.
Duet Biotherapeutics's categories are Biotechnology Research
Duet Biotherapeutics's founding year is 2019
